FluidAI Medical, a pioneer in leveraging artificial intelligence (AI) for postoperative patient monitoring, recently announced that it has raised $15 million in Series A funding. The investment will allow FluidAI to develop deeper medical record integration, expand into existing and new global markets, grow its dynamic team, and introduce novel AI-driven solutions catering to a broader range of postoperative complications.
Fluid AI is an OBIO® member and an alumnus of all OBIO® programs.